BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23185040)

  • 21. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.
    Kim YK; Yu J; Han TS; Park SY; Namkoong B; Kim DH; Hur K; Yoo MW; Lee HJ; Yang HK; Kim VN
    Nucleic Acids Res; 2009 Apr; 37(5):1672-81. PubMed ID: 19153141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
    Qin W; Dong P; Ma C; Mitchelson K; Deng T; Zhang L; Sun Y; Feng X; Ding Y; Lu X; He J; Wen H; Cheng J
    Oncogene; 2012 Sep; 31(36):4067-75. PubMed ID: 22179829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of the miR-212/132 cluster suppresses proliferation of human lung cancer cells.
    Jiang X; Chen X; Chen L; Ma Y; Zhou L; Qi Q; Liu Y; Zhang S; Luo J; Zhou X
    Oncol Rep; 2015 Feb; 33(2):705-12. PubMed ID: 25435090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
    Wang Y; Ma J; Qiu W; Zhang J; Feng S; Zhou X; Wang X; Jin L; Long K; Liu L; Xiao W; Tang Q; Zhu L; Jiang Y; Li X; Li M
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-96 enhances the proliferation of cervical cancer cells by targeting FOXO1.
    Yang L; Liu L; Zhang X; Zhu Y; Li L; Wang B; Liu Y; Ren C
    Pathol Res Pract; 2020 Apr; 216(4):152854. PubMed ID: 32057517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-150-5p May Contribute to Pathogenesis of Human Leiomyoma via Regulation of the Akt/p27
    Lee JH; Choi YS; Park JH; Kim H; Lee I; Won YB; Yun BH; Park JH; Seo SK; Lee BS; Cho S
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.
    Tian RQ; Wang XH; Hou LJ; Jia WH; Yang Q; Li YX; Liu M; Li X; Tang H
    J Biol Chem; 2011 Jul; 286(29):25556-63. PubMed ID: 21646351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
    Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
    PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
    Mao XP; Zhang LS; Huang B; Zhou SY; Liao J; Chen LW; Qiu SP; Chen JX
    J Transl Med; 2015 Mar; 13():86. PubMed ID: 25888950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.
    Zhang GM; Bao CY; Wan FN; Cao DL; Qin XJ; Zhang HL; Zhu Y; Dai B; Shi GH; Ye DW
    PLoS One; 2015; 10(4):e0124410. PubMed ID: 25922934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth.
    Wang HY; Lian P; Zheng PS
    Oncotarget; 2015 Aug; 6(24):20711-22. PubMed ID: 26036262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.
    Wang LQ; Zhang Y; Yan H; Liu KJ; Zhang S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):515-20. PubMed ID: 25747718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
    Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
    J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External Qi of Yan Xin Qigong inhibits activation of Akt, Erk1/2 and NF-ĸB and induces cell cycle arrest and apoptosis in colorectal cancer cells.
    Yan X; Shen H; Jiang H; Hu D; Wang J; Wu X
    Cell Physiol Biochem; 2013; 31(1):113-22. PubMed ID: 23363659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.
    Fu K; Zhang L; Liu R; Shi Q; Li X; Wang M
    World J Surg Oncol; 2020 May; 18(1):115. PubMed ID: 32473637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.